Jean-Luc Henrioul
COO
SEQALIS
Gosselies, Belgium
Walloon Participant
Analytical service provider with qTCR seq for Tcell immune system response studies of immunotherapy treatments and personalized cancer tretaments (eg. personalized neoantigen cancer vaccines).
About me
Analytical service provider upon state-of-the-art platforms such as a quantitative TCR Seq seamless analysis solution, several complementary cytogenomics technologies for the control of the genomic stability and the integrity of ATMPs, and an anatomo-pathology service in the neoantigen cancer vaccines and immuno-oncology fields.
My organisation
SEQALIS
Interests
- Innovation in Life Sciences